Walker & Dunlop Q4 Volume Soars 161% to $18B, Records $29M Loan-Loss and $66M Impairments
Walker & Dunlop ended 2025 as the second-largest GSE loan originator with $17.8 billion in lending volume and 11.2% market share, while Q4 capital markets transactions surged 161% to $18 billion. The company recorded $29 million of Q4 loan loss expense and $66 million of impairments from a $134 million loan review and added new reporting line items.
1. Robust Lending and Capital Markets Growth
Walker & Dunlop closed 2025 as the second-largest GSE loan originator with $17.8 billion of lending volume and 11.2% market share. Multifamily investment sales rose to $4.5 billion in Q4, institutional sales share climbed to 10.2%, and total capital markets transaction volume jumped from $7 billion in Q1 to $18 billion in Q4, a 161% gain.
2. Loan Repurchase Review and Credit Charges
A Freddie Mac-requested review of a $100 million loan portfolio uncovered borrower fraud, leading to an expanded review of 266 loans and identification of $134 million in problematic loans. The firm recorded $29 million of Q4 loan loss expense and took $66 million of impairments tied to these loans and to affordable asset exits, driving a GAAP diluted loss per share of $0.41.
3. Reporting Enhancements and Asset Disposition
To boost transparency, the company introduced two new income-statement line items: “Indemnified and repurchased loan expenses” and “Asset impairments and other expenses.” Since 2024, it has repurchased or indemnified $222 million of loans and plans to sell repurchased and affordable assets over the next few quarters to return $25–35 million of capital and cut $4–5 million of quarterly costs.
4. Dividend Hike and 2026 Guidance
Management raised the quarterly dividend to $0.68 and provided 2026 guidance of $3.50–4.00 diluted EPS and $4.50–5.00 adjusted core EPS. The firm enters Q1 2026 with a $15 billion pipeline and maintains a long-term EPS target of $9 by 2030.